Generic anti-malarial may treat COVID-19 - Raymond James [Seeking Alpha]
AbbVie Inc. (ABBV)
Last abbvie inc. earnings: 5/1 07:43 am
Check Earnings Report
US:NYSE Investor Relations:
investors.abbvie.com/investor-overview
Company Research
Source: Seeking Alpha
Healthcare Generic anti-malarial may treat COVID-19 - Raymond James Mar. 10, 2020 6:23 PM ET | AbbVie Inc. (ABBV) Jason Aycock A generic drug used to treat malaria may be as promising as any that companies are currently scrambling for to treat COVID-19, the coronavirus-related disease spreading rapidly, Raymond James says. Analyst Steven Seedhouse says chloroquine - a longtime oral anti-malarial that costs pennies per dose - could turn out "more effective, scalable, and affordable" than the candidates being studied by companies including AbbVie (NYSE: GILD REGN MRNA GSK PFE After very early indications of efficacy in China, chloroquine is seeing increased demand suggesting it may be seeing real-world use already, though ultimate efficacy d
Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABBV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABBV alerts
High impacting AbbVie Inc. news events
Weekly update
A roundup of the hottest topics
ABBV
News
- AbbVie (ABBV) Stock Moves -0.29%: What You Should Know [Yahoo! Finance]Yahoo! Finance
- Factbox-Widely used drugs on US imports list from Europe [Yahoo! Finance]Yahoo! Finance
- Factbox-Widely used drugs on US imports list from Europe [Yahoo! Finance Canada]Yahoo! Finance Canada
- Oncology Drugs Market Size to Surpass USD 530.39 Billion by 2032, Driven by Advancements in Targeted Therapies and Rising Cancer Incidence – SNS Insider [Yahoo! Finance]Yahoo! Finance
- PESG Report: Silexion Therapeutics' Breakthrough Data Shows SIL204's impact on both Primary Tumors & Metastasis – Signaling a Potential Paradigm Shift in Cancer Treatment [Yahoo! Finance]Yahoo! Finance
ABBV
Earnings
- 1/31/25 - Beat
ABBV
Sec Filings
- 3/18/25 - Form 4
- 3/14/25 - Form 144
- 3/10/25 - Form PRE
- ABBV's page on the SEC website